3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
43
Unknown
10
Terminated
7
Active not recruiting
5
Recruiting
3
Withdrawn
2
Suspended
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
40
Breast Neoplasms
38
Prostatic Neoplasms
24
Colorectal Neoplasms
23
Uterine Cervical Neoplasms
16
Carcinoma, Non-Small-Cell Lung
13
Anxiety Disorders
13
Stomach Neoplasms
9
Lymphoma, Follicular
9
Leukemia, Myeloid, Acute
9
Carcinoma, Hepatocellular
9
Brain Neoplasms
9
Lung Neoplasms
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Esophageal Neoplasms
7
Sarcoma
6
Ovarian Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Depression
6
Colonic Neoplasms
6
Uterine Cervical Dysplasia
5
Small Cell Lung Carcinoma
5
Pain
5
Glioma
5
Epilepsy
5
Dementia
5
Cholangiocarcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Interventional
×
Neurotoxicity Syndromes
×
Clear all
NCT06950190
2025-08-12
(ECCPC)
Ellis Medicine
Phase 3
Enrolling by invitation
100 enrolled